{"@id":"https://bioecon.ru/technology/peptide-matrix-conjugates-for-fibrosis/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/peptide-matrix-conjugates-for-fibrosis/","json":"https://cn.bioecon.ru/api/v1/technology/peptide-matrix-conjugates-for-fibrosis/index.json"},"id":"peptide-matrix-conjugates-for-fibrosis","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/a-costantino-c-spa/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/matrix-sea-foods-india-limited/","https://bioecon.ru/companies/isomerase/","https://bioecon.ru/companies/21st-bio/"]},"maturity":6,"name":"靶向纤维化细胞外基质的多肽基质治疗偶联物","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"纤维化基质新抗原表位淘选"},{"n":2,"title":"抗纤维化小分子共价连接"},{"n":3,"title":"器官组织分布与生物富集"},{"n":4,"title":"组织僵硬度逆转与病理重塑"}],"summary":"针对组织纤维化过程中机械拉伸与交联重塑的细胞外基质 (ECM) 特异性新表位，设计靶向多肽偶联物，实现抗纤维化药物在肺、肝、肾病灶的原位高浓度富集。","url":"/technology/peptide-matrix-conjugates-for-fibrosis/","verified":"2026-11-22"}